-
WA kids to get intranasal flu vax
Thursday | Oct 2 2025THE Western Australian Government has announced it will provide the FluMist intranasal influenza vaccine for children aged two to 12 years next year ahead of the 2026 flu season, a move welcomed by the Pharmaceutical Society of Australia (PSA).
-
Fallout from Choice sunscreen testing continues
Thursday | Oct 2 2025THE Therapeutic Goods Administration (TGA) has confirmed that 20 sunscreens sold in Australia are using the same base formula as Ultra Violette’s Lean Screen, which rated SPF 4 in the Choice sunscreen tests earlier this year (PD 12 Jun), and expressed concerns with the UK testing lab used to provide initial SPF ratings.
-
“Vaccine champ” recognised
Thursday | Oct 2 2025KERRY Savas (pictured), Principal Pharmacist at National Pharmacies Glenelg, has received the 2025 World Pharmacist Day Excellence Award for his “outstanding frontline work” in the vaccination space.
-
FIP hypertension toolkit launched
Thursday | Oct 2 2025THE International Pharmaceutical Federation (FIP) has launched a new Hypertension Pharmacy Toolkit, designed to support pharmacy teams in the prevention, early detection and management of hypertension.
-
Save with APP2026 Tier 1 pricing
Thursday | Oct 2 2025APP2026 is offering a three-tiered registration pricing structure to help improve affordability.
-
Editor’s Choice: Bioderma’s new anti-redness range soothes the skin
Thursday | Oct 2 2025ROSACEA sufferers can now try Bioderma’s new Sensibio AR range, a new anti-redness range the skincare brand has developed alongside dermatologists.
-
Fragrance dupes for men
Thursday | Oct 2 2025AFFORDABLE Aussie beauty label Designer Brands has launched a range of dupes of iconic men’s fragrances (RRP $12.99 each), inspired by luxury labels such as Acqua di Parma, with prices in excess of $300.
-
New 1000 Hour two-in-one trimmer set
Thursday | Oct 2 2025AUSTRALIAN brow brand 1000 Hour makes grooming easy with its new two-in-one Trimmer Set (RRP $34.99).
-
CeraVe stays sun-safe
Thursday | Oct 2 2025JUST in time for summer, CeraVe has released its Facial Moisturising Lotion with SPF50 (RRP $26.99), formulated with ceramides, hyaluronic acid and niacinamide to nourish and protect the skin.
-
Pfizer declines AD drug PBS listing
Thursday | Oct 2 2025PFIZER has decided not to go ahead with the listing of atopic dermatitis drug Cibinqo (abrocitinib) on the Pharmaceutical Benefits Scheme (PBS), citing economic considerations.
PARTNER SITES
to top